These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 194988)
1. Effect of erythropoietin preparations on cyclic AMP and cyclic GMP levels in rat fetal liver cell cultures. Graber SE; Bomboy JD; Salmon WD; Krantz SB J Lab Clin Med; 1977 Jul; 90(1):162-70. PubMed ID: 194988 [No Abstract] [Full Text] [Related]
2. Lack of effect of erythropoietin on cyclic adenosine-3',5'-monophosphate levels in rat fetal liver cells. Graber SE; Carrillo M; Krantz SB J Lab Clin Med; 1974 Feb; 83(2):288-95. PubMed ID: 4359408 [No Abstract] [Full Text] [Related]
3. Increased concentrations of cyclic GMP in fetal liver cells stimulated by erythropoietin. White LE; George WJ Proc Soc Exp Biol Med; 1981 Feb; 166(2):186-93. PubMed ID: 6163152 [No Abstract] [Full Text] [Related]
4. Role of erythropoietin and cyclic nucleotides in erythroid cell proliferation in fetal liver. White L; Fisher JW; George WJ Exp Hematol; 1980; 8 Suppl 8():168-81. PubMed ID: 6297942 [TBL] [Abstract][Full Text] [Related]
5. Evidence that endotoxin is the cyclic 3':5'-GMP--promoting factor in erythropoietin preparations. Graber SE; Bomboy JD; Salmon WD; Krantz SB J Lab Clin Med; 1979 Jan; 93(1):25-31. PubMed ID: 215681 [TBL] [Abstract][Full Text] [Related]
6. Xanthines and skeletal muscle: lack of relationship between phosphodiesterase inhibition and increased twitch tension in rat diaphragms. Kramer GL; Wells JN Mol Pharmacol; 1980 Jan; 17(1):73-8. PubMed ID: 6247639 [No Abstract] [Full Text] [Related]
8. [Cyclic guanosine-3',5'-monophosphate--mediator of the action of the hormaone erythropoietin]. Fedorov NA; Ermil'chenko GV; Malykhina IS; Borisov BN Dokl Akad Nauk SSSR; 1977 Apr; 233(5):985-8. PubMed ID: 18327 [No Abstract] [Full Text] [Related]
9. Inhibition of neoplastic cell growth by quiescent cells is mediated by serum concentration and cAMP phosphodiesterase inhibitors. Bertram JS; Bertram BB; Janik P J Cell Biochem; 1982; 18(4):515-38. PubMed ID: 6282911 [No Abstract] [Full Text] [Related]
10. Cyclic AMP phosphodiesterase in human lymphocytes and lymphoblasts. Takemoto DJ; Lee WN; Kaplan SA; Appleman MM J Cyclic Nucleotide Res; 1978 Apr; 4(2):123-32. PubMed ID: 207751 [TBL] [Abstract][Full Text] [Related]
11. The effect of cyclic AMP on heme synthesis by rat bone marrow cells. Graber SE; Carrillo M; Krantz SB Proc Soc Exp Biol Med; 1972 Oct; 141(1):206-10. PubMed ID: 4343189 [No Abstract] [Full Text] [Related]
12. [Effects of acute ethanol load on plasma and hepatic cyclic nucleotides, plasma catecholamine and glucagon in rats. 1. Effects of acute ethanol load on cyclic AMP and cyclic GMP in rat blood and liver]. Ide T Arukoru Kenkyuto Yakubutsu Ison; 1984 Sep; 19(3):173-84. PubMed ID: 6100432 [No Abstract] [Full Text] [Related]
13. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine. Miot F; Erneux C; Wells JN; Dumont JE Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949 [TBL] [Abstract][Full Text] [Related]
14. Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP. Liu H; Maurice DH Br J Pharmacol; 1998 Dec; 125(7):1501-10. PubMed ID: 9884079 [TBL] [Abstract][Full Text] [Related]
15. Ornithine decarboxylase induction in liver- and hepatoma-derived cell cultures: no detectable differences between control and 3-methylcholanthrene-treated cells. Kano I; Nebert DW Mol Pharmacol; 1981 Jul; 20(1):172-8. PubMed ID: 6270530 [No Abstract] [Full Text] [Related]
16. Alpha adrenergic involvement in heart metabolism: effects on adenosine cyclic 3',5'-monophosphate, adenosine cyclic 3',5'-monophosphate-dependent protein kinase, guanosine cyclic 3',5'-monophosphate, and glucose transport. Keely SL; Corbin JD; Lincoln T Mol Pharmacol; 1977 Sep; 13(5):965-75. PubMed ID: 197396 [No Abstract] [Full Text] [Related]
17. Dynamic changes of post-ischemic hepatic microcirculation improved by a pre-treatment of phosphodiesterase-3 inhibitor, milrinone. Kume M; Banafsche R; Yamamoto Y; Yamaoka Y; Nobiling R; Gebhard MM; Klar E J Surg Res; 2006 Dec; 136(2):209-18. PubMed ID: 17045613 [TBL] [Abstract][Full Text] [Related]
18. Potentiation of the effects of sodium nitroprusside and of isoproterenol by selective phosphodiesterase inhibitors. Lorenz KL; Wells JN Mol Pharmacol; 1983 Mar; 23(2):424-30. PubMed ID: 6300651 [TBL] [Abstract][Full Text] [Related]
19. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics. Weishaar RE; Quade MM; Schenden JA; Evans DB J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170 [TBL] [Abstract][Full Text] [Related]
20. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes. Hoskins B; Luong HB Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]